NCT07480902 2026-03-18
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Timser SAPI de CV
Phase NA Recruiting
Clinical Trials
65 trialsNCT06979180 2026-03-05
A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
Papillex Inc.
Phase NA Recruiting
NCT07211204 2026-03-03
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Timser SAPI de CV
Phase NA Withdrawn
NCT05502367 2026-02-19
A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia
Antiva Biosciences
Phase 1/2 Terminated
NCT06815939 2026-01-29
OPTICS
DL Analytics
Phase NA Recruiting
NCT04098744 2025-10-02
ART-CIN_IIB
Frantz Viral Therapeutics, LLC
Phase 2 Recruiting
NCT04915495 2025-03-21
The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia
Guided Therapeutics
Phase NA Enrolling by invitation
NCT05496231 2025-02-03
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
GlaxoSmithKline
Phase 1/2 Completed
NCT06776055 2025-01-15
Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
Shanghai Zerun Biotechnology Co.,Ltd
Active not recruiting
NCT03493542 2024-12-31
V501-213
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03721978 2024-10-17
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Inovio Pharmaceuticals
Phase 3 Completed
NCT03629886 2024-03-15
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
GlaxoSmithKline
Phase 4 Completed
NCT03549273 2024-02-07
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Phase 2 Unknown
NCT03185013 2023-07-27
REVEAL 1
Inovio Pharmaceuticals
Phase 3 Completed
NCT02740777 2023-04-13
Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
Shanghai Zerun Biotechnology Co.,Ltd
Phase 2 Completed
NCT04312737 2023-01-06
EU-VALHUDES
Hiantis Srl
Completed
NCT02733068 2022-12-19
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Shanghai Zerun Biotechnology Co.,Ltd
Phase 3 Completed
NCT05426148 2022-06-29
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Xiamen Innovax Biotech Co., Ltd
Phase 4 Completed
NCT03438006 2021-09-08
A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects
GlaxoSmithKline
Completed
NCT03697226 2021-01-13
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Antiva Biosciences
Phase 1 Completed
NCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT02185599 2020-03-13
IMPROVE-COLPO
DySIS Medical Inc.
Completed
NCT04073082 2019-08-30
Safety and Efficacy of Laser Therapy in Gynaecology
Juna d.o.o.
Unknown
NCT03239223 2019-07-10
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Antiva Biosciences
Phase 1 Completed
NCT02631863 2019-07-08
Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT02304770 2019-06-12
Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT00128661 2019-03-08
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
GlaxoSmithKline
Phase 3 Completed
NCT01544478 2018-11-28
V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT01304524 2018-09-07
HPV-003
Inovio Pharmaceuticals
Phase 2 Completed
NCT02576561 2017-10-25
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
THEVAX Genetics Vaccine
Phase 2 Unknown
NCT03143491 2017-10-18
Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)
DFB Soria, LLC
Phase 2 Withdrawn
NCT02100085 2017-07-12
Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation
Genexine, Inc.
Unknown
NCT02139267 2017-07-12
Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia
Genexine, Inc.
Phase 2 Completed
NCT02411019 2017-07-12
GX-188E
Genexine, Inc.
Unknown
NCT02596243 2017-07-12
Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)
Genexine, Inc.
Phase 2 Unknown
NCT00337818 2017-05-30
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women
GlaxoSmithKline
Phase 3 Completed
NCT01345279 2017-05-30
Indirect Comparison Topotecan Cervical Carcinoma
GlaxoSmithKline
Completed
NCT00973362 2017-01-06
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Gen-Probe, Incorporated
Phase 3 Completed
NCT00929526 2016-10-20
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
GlaxoSmithKline
Phase 3 Completed
NCT00312286 2016-09-23
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Takeda
Phase 2 Terminated
NCT00117884 2016-08-19
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Takeda
Phase 2 Terminated
NCT01022346 2016-08-15
A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection
Hoffmann-La Roche
Phase 2 Completed
NCT01116245 2016-07-27
ADXS11-001
Advaxis, Inc.
Phase 2 Terminated
NCT01256424 2016-05-16
Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia
Photocure
Phase 2 Completed
NCT02195089 2016-04-19
Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)
BioLeaders Corporation
Phase 1/2 Completed
NCT00154089 2016-02-23
A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
Erimos Pharmaceuticals
Phase 1/2 Completed
NCT01826045 2016-01-29
PGA
BioLeaders Corporation
Phase 2 Completed
NCT02605941 2015-11-17
DNA Methylation Biomarkers for Cervical Cancer Screening
iStat Biomedical CO., Ltd.
Unknown
NCT02016833 2015-04-30
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
Completed
NCT01634503 2014-02-17
CIN3
Genexine, Inc.
Phase 1 Completed